Key result
The combination of G-CSF and myelosuppressives significantly improved left ventricular ejection fraction, reduced left ventricular remodeling, and enhanced myocardial repair compared to G-CSF alone or saline in a rabbit model of myocardial infarction.
Why the study?
Does the combination of G-CSF and myelosuppressives improve myocardial repair and cardiac function in a rabbit model of post-myocardial infarction?
Does the combination of G-CSF and myelosuppressives improve myocardial repair and cardiac function in a rabbit model of post-myocardial infarction?
p-value: p=<0.05
The combination of G-CSF and myelosuppressives synergistically improves post-MI cardiac function and reduces remodeling in a rabbit model by enhancing stem cell recruitment via the CXCR4/SDF-1 axis.
No takes yet. Share an insight, caveat, or question.
Should not alter practice; leaves open translation of G-CSF combinations to human post-MI trials.
Misao et al. (2007) studied Myocardial Infarction (n=160). G-CSF combined with myelosuppressives (5-fluorouracil and cyclophosphamide) vs. Saline, G-CSF alone, or myelosuppressives alone was evaluated on Left ventricular ejection fraction and end-diastolic dimension at 28 days post-MI (p=<0.05). The combination of G-CSF and myelosuppressives significantly improved left ventricular ejection fraction, reduced left ventricular remodeling, and enhanced myocardial repair compared to G-CSF alone or saline in a rabbit model of myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: